Search Results - "Ruiz de Lobera, A."

Refine Results
  1. 1
  2. 2

    Preoperative chemoradiotherapy with capecitabine and oxaliplatin in patients with locally advanced rectal cancer by Marrodan, I., Azkona, E., Carrera, S., Aresti, U., Calvo, B., Buque, A., Sancho, A., Ruiz de Lobera, A., Munoz Llarena, A., Lopez-Vivanco, G.

    Published in Journal of clinical oncology (01-02-2011)
    “…Abstract only 548 Background: Locally advanced rectal carcinoma is associated with high rate of abdomino-perineal amputation. We analyzed a cohort of patients…”
    Get full text
    Journal Article
  3. 3

    Gemcitabine (G) fixed-dose-rate infusion (FDR) plus erlotinib (E) in patients with advanced pancreatic cancer (APC) by Munoz Llarena, A., Mane, J., Lopez-Vivanco, G., de Lobera, A. Ruiz, Sancho, A., Iruarrizaga, E., Arruti, M., Marrodan, I., Fuente, N., Ballesteros, D.

    Published in Journal of clinical oncology (01-02-2011)
    “…Abstract only 304 Background: G (30-minute infusion) plus E improves survival in patients with APC compared with G alone. In a recent phase III trial, G-FDR…”
    Get full text
    Journal Article
  4. 4

    Potential diagnostic markers in bronchial fluid of small cell lung cancer (SCLC) by Carrera Revilla, S., Muñoz, A., Zalacain, R., López-Vivanco, G., Uribarri, M., Simón, L., Calvo, B., Jangi, M., Rubio, I., Ruiz de Lobera, A.

    Published in Journal of clinical oncology (20-05-2009)
    “…Abstract only e22221 Background: Lung cancer is a major cause of mortality worldwide and overall survival rate has not improved significantly over the past 20…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    First-line docetaxel (Dx) and capecitabine (Cap) in advanced head and neck cancer by Gil-Negrete, A., Mañe, J. M., Ruiz de Lobera, A., Martinez-Bueno, A., Rubio, I., Fuente, N., Lopez-Vivanco, G., Ancizar, N., Fernandez, R., Sancho, A.

    Published in Journal of clinical oncology (20-06-2007)
    “…Abstract only 16505 Background: Dx and Cap are useful drugs in head and neck cancer. Our purpose was to establish the efficacy and safety of this combination…”
    Get full text
    Journal Article
  10. 10

    Nasopharyngeal carcinoma: Comparison of concomitant chemoradiotherapy with neoadjuvant chemotherapy in the caucasian population by Sancho, A., Rubio, I., Diaz de Corcuera, I., Munoz, A., Martinez-Bueno, A., Mane, J. M., Ruiz de Lobera, A., Fernandez-Rodriguez, R., Gil-Negrete, A., Carrera, S.

    Published in Journal of clinical oncology (20-06-2007)
    “…Abstract only 16532 Background: Nowadays, concomitant chemoradiotherapy (CT-RT) is the standard treatment for nasopharyngeal carcinoma (NPC). Neoadyuvant…”
    Get full text
    Journal Article
  11. 11

    Treatment of locally advanced esophageal carcinoma with induction cisplatin-paclitaxel-5FU (PTF) before local therapy by Fernandez-Rodriguez, R., Ancizar, N., Lopez de Argumedo, G., Ruiz de Lobera, A., Lopez Vivanco, G., Gil Negrete, A., Sancho, A., Carrera, S., Munoz, A., Mane, J. M.

    Published in Journal of clinical oncology (20-06-2007)
    “…Abstract only 15174 Background: We analyse induction therapy with PTF before local definitive therapy in terms of response, resectability, toxicity and…”
    Get full text
    Journal Article
  12. 12

    Biweekly schedule of cisplatin with prolonged infusion of gemcitabine in advanced non small cell lung cancer (NSCLC) by López-Vivanco, G., Rubio, I., Mañé, J., Viteri, A., Ancizar, N., Muñoz, A., Barceló, R., Fuente, N., Ruiz de Lobera, A., López-Argumedo, G.

    Published in Journal of clinical oncology (20-06-2006)
    “…Abstract only 17093 Background: Firstly, we conducted a phase I of a biweekly schedule of cisplatin with prolonged infusion of gemcitabine (10 mg/m 2 /min) and…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20